One shot, seven days: Long-acting levodopa gel tackles Parkinson’s tremors
AUSTRALIA, JUL 14 – The new weekly injectable maintains steady medication levels, reducing side effects and improving treatment for more than 8 million Parkinson’s patients, researchers said.
8 Articles
8 Articles
Nothing helped Kenneth Mårtensson's tremors – until he tried ultrasound in the brain. The new treatment, which can also help Parkinson's patients, burns away part of the brain. “It's magic,” says Kenneth when he can hold a coffee mug without spilling.
Smart brain-zapping implants could revolutionize Parkinson’s treatment
The next generation of deep-brain stimulation automatically corrects the precise brain waves that create symptoms of Parkinson’s disease. Can this approach target other conditions? The next generation of deep-brain stimulation automatically corrects the precise brain waves that create symptoms of Parkinson’s disease. Can this approach target other conditions?

One shot, seven days: Long-acting levodopa gel tackles Parkinson’s tremors
Researchers in Australia have created a biodegradable gel that delivers Parkinson’s medications through a single weekly shot, replacing the need for multiple daily pills. Injected just under the skin, the gel steadily releases levodopa and carbidopa for seven days, helping keep tremors and stiffness in check while easing side effects linked to fluctuating doses.
Impact of Newer Therapies on Dyskinesia in Parkinson Disease
Panelists discuss how newer Parkinson disease therapies may impact dyskinesia management by potentially providing continuous dopaminergic stimulation that could prevent dyskinesia development if used early, though current evidence from phase 3 trials shows mixed results with improvements in "good on time" (on time without troublesome dyskinesia) but limited reduction in existing troublesome dyskinesia, suggesting that while these treatments offe…
Parkinson’s vaccine could replace the need for daily tablets
Researchers believe the treatment could transform the lives of more than eight million people who live with the condition. Parkinson’s is a condition that targets the brain. The disease damages nerve cells, which, overtime, cause people to suffer with tremors, slow movement and stiff, inflexible muscles. Currently there is no cure for the illness, but treatments have been created to help reduce symptoms and improve people’s quality of life. In l…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium